By: Paige Bond Movement requires communication between both muscles and nerves. At the neuromuscular junction (Figure 1), nerves release a chemical messenger, acetylcholine, which binds to specific receptors on muscle cells to trigger muscle contraction. Disrupting the activity of the acetylcholine receptors can lead to muscle weakness or the inability to voluntarily contract muscles at … Continue reading Moving beyond COVID: mRNA Steps into CAR T cell therapy for Myasthenia Gravis
therapeutic
The Life of Aducanumab: A Potential Novel Alzheimer’s Disease Drug
On October 22nd, 2019, headlines read “Biogen plans regulatory filing for Aducanumab for Alzheimer’s disease based on new analysis of larger dataset from phase 3 studies”. Alzheimer’s disease (AD) is a devastating neurodegenerative disease characterized by cognitive dysfunction and memory loss. It is the 6th leading cause of adult deaths in the United States. Biogen … Continue reading The Life of Aducanumab: A Potential Novel Alzheimer’s Disease Drug
Lions Talk Science 